Tag: Cancer: Prostate
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
Novel Biomarkers Identified for Prostate Cancer in Non-Blacks
PCA3 and T2ERG add utility for predicting prostate cancer when combined with PCPT risk calculator
ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
Substantial Increase in Costs With Metastases in Prostate CA
Costs peak during month of metastases diagnosis, reaching $13,291
Combined Urine Test for T2:ERG, PCA3 Ups Prostate CA Detection
Combined urinary testing can avoid unnecessary prostate biopsy, while preserving high sensitivity
Distinct Outcomes for Luminal-, Basal-Like Prostate Cancers
Luminal B prostate cancers exhibited poorest clinical prognosis in univariate, multivariate analyses
Black Men Have Higher Rate of Preclinical Prostate Cancer
Also increased risk of progression to metastatic disease compared with the general population
PSA Screening Rates Have Leveled Off in U.S.
Decline followed recommendations from U.S. Preventive Services Task Force
Surveillance Biopsy Timing Not Tied to Reclassification
But PSA density and body mass index are associated with prostate cancer reclassification
Yoga Helps Ease Side Effects of Prostate Cancer Treatment
Men who attended yoga classes had less fatigue and better sexual and urinary function
